F-group (family)
323.1.1.6 Carn_acyltransf
Ligands and drugs
227
Member domains
80
with ligand contacts (≤ 4 Å)
35.2% of members
81
with DrugDomain annotations
35.7% of members
59
with a DrugBank compound
26.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 323.1.1.6 belongs to X-group 323 CoA-dependent acyltransferases, which binds 9.6 ligand superclasses per 20 proteins, broader than 90% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01992 | COA | Coenzyme A | 23 |
| DB02648 | 152 | (3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium | 23 |
| DB03796 | PLM | Palmitic Acid | 6 |
| DB00583 | — | — | 4 |
| DB03832 | OCB | 3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium | 3 |
| DB00122 | CHT | Choline | 2 |
| DB01074 | — | — | 2 |
| DB00184 | — | Nicotine | 1 |
| DB01016 | — | Glyburide | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| 152 | CARNITINE | 22 |
| COA | COENZYME A | 22 |
| PLM | PALMITIC ACID | 6 |
| NAmetal | SODIUM ION | 5 |
| BUJ | (3R)-3-(hexadecanoylamino)-4-(trimethylammonio)butanoate | 4 |
| D12 | DODECANE | 4 |
| HC5 | (R)-3-CARBOXY-2-(HEXANOYLOXY)-N,N,N-TRIMETHYLPROPAN-1-AMINIUM | 4 |
| L0R | 1-[(2R)-2-(3,4-dihydroisoquinolin-2(1H)-ylcarbonyl)piperidin-1-yl]-2-phenoxyethanone | 4 |
| P6G | HEXAETHYLENE GLYCOL | 4 |
| 0RD | 4-[({1-[(5-chloro-2-methoxyphenyl)sulfonyl]-4-methyl-2,3-dihydro-1H-indol-6-yl}carbonyl)amino]benzoic acid | 2 |
| 0RK | 2-chloro-4-[({1-[(5-chloro-2-methoxyphenyl)sulfonyl]-4-methyl-2,3-dihydro-1H-indol-6-yl}carbonyl)amino]benzoic acid | 2 |
| A1IAO | 1-methyl-4-(2-naphthalen-1-ylethyl)-4H-pyridine | 2 |
| A1IAP | 1-methyl-4-[(2S)-2-naphthalen-1-yl-2-propylsulfanyl-ethyl]-4H-pyridine | 2 |
| ACO | ACETYL COENZYME *A | 2 |
| BUI | (3R)-3-{[(TETRADECYLAMINO)CARBONYL]AMINO}-4-(TRIMETHYLAMMONIO)BUTANOATE | 2 |
| CHT | CHOLINE ION | 2 |
| OCB | OCTANOYLCARNITINE | 2 |
| RMW | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(3~{R})-2,2-dimethyl-4-[[3-[2-[(1~{R})-2-(1-methylpyridin-4-yl)-1-naphthalen-1-yl-ethyl]sulfanylethylamino]-3-oxidanylidene-propyl]amino]-3-oxidanyl-4-oxidanylidene-butyl] hydrogen phosphate | 2 |
| SOP | [(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-HYDROXY-3-(PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]METHYL(3R)-3-HYDROXY-2,2-DIMETHYL-4-OXO-4-{[3-OXO-3-({2-[(2-OXOPROPYL)THIO]ETHYL}AMINO)PROPYL]AMINO}BUTYL DIHYDROGENDIPHOSPHATE | 2 |